The Canadian Nuclear Isotope Council partners with NUCM to strengthen Canada’s nuclear medicine industry
Toronto – May 15, 2024– NUCM, a Canadian company that produces GMP Radiopharmaceuticals crucial for medical imaging and treatments, has joined the Canadian Nuclear Isotope Council (CNIC). NUCM is a source for all commonly-used Tc-99m SPECT radiopharmaceuticals and continue to